ARKK vs TMFX

Key Takeaways

• ARK Innovation ETF (ARKK) is an actively managed thematic fund focused on disruptive innovation across multiple sectors, while Motley Fool Next Index ETF (TMFX) is a passively managed fund tracking a proprietary index of small- and mid-cap U.S. companies recommended by Motley Fool analysts.
• ARKK typically holds 35-55 stocks with concentrated positions in high-conviction innovation names, whereas TMFX maintains broader exposure with approximately 150-200 holdings for greater diversification.
• ARKK carries a higher expense ratio of 0.75% compared to TMFX's 0.50%, reflecting its active management approach versus TMFX's rules-based indexing strategy.
• Sector allocations in ARKK emphasize technology, healthcare, and consumer discretionary tied to themes like artificial intelligence (AI) and genomics, while TMFX offers balanced exposure across technology, industrials, consumer cyclical, and healthcare with a small- and mid-cap bias.
• ARKK's active rebalancing allows flexibility in response to innovation trends, whereas TMFX follows a market-cap-weighted index with periodic adjustments based on analyst recommendations and ratings.
• Both ETFs target growth-oriented investors but differ in risk profiles, with ARKK exhibiting higher concentration risk and TMFX providing broader small- and mid-cap market access at lower cost.

Introduction

ARK Innovation ETF (ARKK) and Motley Fool Next Index ETF (TMFX) represent distinct approaches to growth investing in U.S. equities. ARKK pursues active, thematic exposure to disruptive innovation, while TMFX delivers passive access to small- and mid-cap companies selected through analyst-driven research. These ETFs do not compete directly but offer investors alternative strategies for capturing innovation and growth themes, appealing to those seeking either concentrated high-conviction bets or diversified small- and mid-cap opportunities in the current market environment.

ARK Innovation ETF (ARKK) Overview

ARK Innovation ETF (ARKK) is an actively managed exchange-traded fund (ETF) that seeks long-term growth of capital by investing primarily in domestic and foreign equity securities of companies relevant to its theme of disruptive innovation. The fund typically holds 35-55 stocks, with top holdings often including TSLA, TEM, CRSP, and COIN. Sector allocations concentrate in technology, healthcare, and consumer discretionary, reflecting exposure to areas such as artificial intelligence (AI), genomics, fintech, and autonomous technology. The expense ratio stands at 0.75%. As a non-diversified, active thematic vehicle, ARKK features high-conviction stock selection with periodic rebalancing driven by the manager's innovation-focused research process.

Motley Fool Next Index ETF (TMFX) Overview

Motley Fool Next Index ETF (TMFX) is a passively managed ETF designed to track the Motley Fool Next Index, a proprietary, rules-based benchmark of U.S. small- and mid-cap companies that are actively recommended by Motley Fool analysts or rank among the highest-rated in the firm's database. The fund holds approximately 150-200 securities, with top holdings typically including companies such as FIX, UI, and WAB. Sector weightings feature technology, industrials, consumer cyclical, and healthcare. The expense ratio is 0.50%. TMFX employs physical replication of the index with market-cap weighting and periodic rebalancing to maintain alignment with the underlying rules-based methodology.

Industry and Thematic Backdrop

The broader environment for both ETFs centers on U.S. equity growth themes, particularly innovation-driven sectors and small- and mid-cap opportunities. Capital flows continue toward companies advancing artificial intelligence (AI), biotechnology, and digital infrastructure, supported by technological advancements and corporate adoption cycles. Regulatory developments around data privacy, antitrust scrutiny in technology, and healthcare innovation influence positioning. Macroeconomic drivers include interest rate expectations and economic growth trends that affect capital allocation between large-cap leaders and smaller growth companies. Sector risks encompass valuation compression in high-growth areas, supply chain disruptions, and shifts in investor sentiment toward value or defensive strategies during periods of economic uncertainty.

Performance and Positioning Comparison

In recent market cycles, ARKK has demonstrated higher volatility tied to the performance of its concentrated innovation holdings, with positioning influenced by sector rotation toward or away from technology and healthcare themes. TMFX has shown more moderate volatility consistent with its diversified small- and mid-cap profile and rules-based construction. Relative positioning highlights ARKK's sensitivity to earnings momentum in disruptive companies and interest rate environments favoring growth assets, while TMFX benefits from broader exposure to analyst-recommended names across multiple sectors. Both ETFs reflect ongoing capital allocation trends between concentrated thematic strategies and diversified small- and mid-cap approaches.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Investors seeking data-driven insights into ETFs like ARKK and TMFX may find the tool useful for refining their research process.

Tickeron AI Verdict

Based on observable structural factors, Tickeron’s AI would currently assign a higher probability of favor to ARK Innovation ETF (ARKK) due to its concentrated exposure to disruptive innovation themes, which align with sustained sector momentum in technology and healthcare, despite the higher expense ratio. TMFX offers compelling cost efficiency and diversification but trails in thematic specificity. This assessment reflects probabilistic evaluation of structural strength and positioning rather than a guarantee of future results.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations